Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization ...Middle East

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining the current process for emergency use authorization for mild-to-moderate COVID-19 patients, Hyundai Bioscience will expedite Phase 3 clinical...

Hence then, the article about hyundai bioscience to conduct phase 3 clinical trial for high risk group of covid 19 patients with the goal of emergency use authorization was published today ( Wednesday 28/08/2024 - 12:42 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization )

Also on site :

• Country Star Left Bleeding After Getting Struck in Face by Fan’s Phone
• ‘My mother was tricked by a fraudster pretending to be David Attenborough and gave them half of her life savings’
• Two weeks of war: Inside Trump’s risky decision to attack Iran — and the scramble to contain the fallout